SWOT Analysis for X4 Pharmaceuticals Inc

30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over Half Year (6 Months)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Stock gained more than 20% in one month
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Highest Recovery from 52 Week Low

Promoter decreasing their shareholding
Companies with growing costs YoY for long term projects
Momentum Trap (DVM)
Promoter holding decreased by more than -2% QoQ
Companies with High Debt
Negative profit growth, promoters decreasing shareholding QoQ
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Companies with Increasing Debt
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years
Profit to Loss Companies
Stocks Underperforming their Industry Price Change in the Quarter